Durvalumab Plus Tremelimumab With Concurrent Radiotherapy for Localized Muscle Invasive Bladder Cancer Treated With a Selective Bladder Preservation Approach
about
Durvalumab Plus Tremelimumab With Concurrent Radiotherapy for Localized Muscle Invasive Bladder Cancer Treated With a Selective Bladder Preservation Approach
description
A clinical trial related to cancer immunotherapy, retrieved from clinicaltrials.gov
@en
klinisch onderzoek
@nl
name
Durvalumab Plus Tremelimumab W ...... Bladder Preservation Approach
@en
Durvalumab Plus Tremelimumab W ...... Bladder Preservation Approach
@nl
type
label
Durvalumab Plus Tremelimumab W ...... Bladder Preservation Approach
@en
Durvalumab Plus Tremelimumab W ...... Bladder Preservation Approach
@nl
prefLabel
Durvalumab Plus Tremelimumab W ...... Bladder Preservation Approach
@en
Durvalumab Plus Tremelimumab W ...... Bladder Preservation Approach
@nl
P4844
P1050
P3098
NCT03702179